Search Tag: Blueprint Medicines

Executive Health Management

2022 23 Jun

Blueprint Medicines Corporation announced the appointment of  Habib Dable  to its board of directors. Mr. Dable, who was Chief Executive Officer of Acceleron Pharma from 2016 to 2021, brings nearly 30 years of experience in strategic leadership, commercial growth and organizational scale across global pharmaceutical and emerging biotechnology companies....Read more